FDA Updates Johnson & Johnson (Janssen) COVID-19 Vaccine Fact Sheet
Last week the Food and Drug Administration (FDA) announced the revision of the Johnson & Johnson (Janssen) COVID-19 Vaccine fact sheet to include information regarding the increased risk of Guillain-Barré Syndrome (GBS) following vaccination. This reaction stems from an immune response to the vaccine wherein damage is caused to nerve cells, causing muscle weakness and, in some cases, paralysis. The FDA reports that there have been 100 cases reported after 12.5 million doses have been administered. 95 of these cases were severe and required hospitalizations, with one death reported. No similar side effect has been seen with the Moderna or Pfizer-BioNTech COVID-19 vaccines.
Independent Pharmacy COVID-19 Vaccine Incentives for Medicaid Patients: July 21 Survey Deadline
Independent pharmacies have two options to incentivize Medicaid patients who get their first COVID-19 shot at their pharmacy.
Please ensure that the gift card tracker documents have patient information specific to each managed care plan and that the information is sent securely via email to protect patient data. Vaccinators can use this COVID-19 Vaccine Gift Card Tracker Example.
Helpful State Vaccine Resources and Information
The following resources are helpful for vaccinators to contact ODH regarding vaccine shipments:
OPA is working diligently to facilitate communication between state decision-makers and member pharmacists. OPA has created multiple COVID-19 resources, including a COVID-19 Vaccine Information Webpage, COVID-19 Testing Hub, and COVID-19 Resources Webpage, on the OPA website www.ohiopharmacists.org under the Resources drop-down box. For further questions, please contact Myriam Shaw Ojeda, Fellow in Policy and Innovation, at firstname.lastname@example.org.